Literature DB >> 12648170

Unexplained antepartum fetal death in Norway, 1985-97: diagnostic validation and some epidemiologic aspects.

Svein Rasmussen1, Susanne Albrechtsen, Lorentz M Irgens, Knut Dalaker, Helga Maartmann-Moe, Ljiljana Vlatkovic, Trond Markestad.   

Abstract

OBJECTIVE: To validate the diagnosis of an unexplained antepartum fetal death in the Medical Birth Registry of Norway against data obtained from hospital records, alone and combined with autopsy data. To compare epidemiologic characteristics of an unexplained fetal death based on cases recorded by the three data sources.
METHODS: Data on unexplained fetal deaths in the Registry were compared with clinical and autopsy data from 108 457 singletons with a gestational age >or= 28 weeks or a birthweight >or= 1000 g delivered in 1985-97 at Haukeland Hospital in Bergen and Aker Hospital in Oslo.
RESULTS: Compared with clinical data, the positive and negative predictive values of a Registry diagnosis of an unexplained fetal death were 88% and 86%, respectively, while the sensitivity and specificity were 76% and 93%, respectively. Compared with clinical and autopsy data combined, the positive and negative predictive values of a Registry diagnosis of an unexplained fetal death were 77% and 89%, respectively, while the sensitivity and specificity were 78% and 88%, respectively. High agreement was observed in comparisons between the data sources of risks according to various independent variables.
CONCLUSIONS: The validity of a diagnosis of an unexplained antepartum fetal death based on the Medical Birth Registry of Norway is sufficiently high to justify future large-scale epidemiologic studies based on this database.

Entities:  

Mesh:

Year:  2003        PMID: 12648170     DOI: 10.1034/j.1600-0412.2003.00009.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  7 in total

1.  Risk of fetal death after pandemic influenza virus infection or vaccination.

Authors:  Siri E Håberg; Lill Trogstad; Nina Gunnes; Allen J Wilcox; Håkon K Gjessing; Sven Ove Samuelsen; Anders Skrondal; Inger Cappelen; Anders Engeland; Preben Aavitsland; Steinar Madsen; Ingebjørg Buajordet; Kari Furu; Per Nafstad; Stein Emil Vollset; Berit Feiring; Hanne Nøkleby; Per Magnus; Camilla Stoltenberg
Journal:  N Engl J Med       Date:  2013-01-16       Impact factor: 91.245

2.  Hyperemesis gravidarum and pregnancy outcomes in the Norwegian Mother and Child Cohort - a cohort study.

Authors:  Åse V Vikanes; Nathalie C Støer; Per Magnus; Andrej M Grjibovski
Journal:  BMC Pregnancy Childbirth       Date:  2013-09-03       Impact factor: 3.007

3.  Hyperemesis gravidarum in the Medical Birth Registry of Norway - a validity study.

Authors:  Åse Vikanes; Per Magnus; Siri Vangen; Sølvi Lomsdal; Andrej M Grjibovski
Journal:  BMC Pregnancy Childbirth       Date:  2012-10-24       Impact factor: 3.007

4.  Prevalence, risk factors and outcomes of velamentous and marginal cord insertions: a population-based study of 634,741 pregnancies.

Authors:  Cathrine Ebbing; Torvid Kiserud; Synnøve Lian Johnsen; Susanne Albrechtsen; Svein Rasmussen
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

5.  Intrauterine growth restriction: effects of physiological fetal growth determinants on diagnosis.

Authors:  Kjell Haram; Eirik Søfteland; Radek Bukowski
Journal:  Obstet Gynecol Int       Date:  2013-06-23

6.  Extreme umbilical cord lengths, cord knot and entanglement: Risk factors and risk of adverse outcomes, a population-based study.

Authors:  Lorentz Erland Linde; Svein Rasmussen; Jörg Kessler; Cathrine Ebbing
Journal:  PLoS One       Date:  2018-03-27       Impact factor: 3.240

7.  Seasonal and pandemic influenza during pregnancy and risk of fetal death: A Norwegian registry-based cohort study.

Authors:  Nina Gunnes; Håkon Kristian Gjessing; Inger Johanne Bakken; Sara Ghaderi; Jon Michael Gran; Olav Hungnes; Per Magnus; Sven Ove Samuelsen; Anders Skrondal; Camilla Stoltenberg; Lill Trogstad; Allen J Wilcox; Siri Eldevik Håberg
Journal:  Eur J Epidemiol       Date:  2020-01-16       Impact factor: 8.082

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.